Asthma and Hay Fever Seem to Protect Against Cancer Death
By Michael Smith , MedPage Today Staff Writer - Reviewed by Rubeen K. Israni, M.D., Fellow, Renal-Electrolyte
and Hypertension Division, University of Pennsylvania School of Medicine
MedPage Today Action Points
• Advise patients that this study found an inverse association between asthma and hay fever and
all-cancer mortality.
• Note that the study analyzed a very large database of information, collected over 18 years of
follow-up, but it is not a randomized trial.
OTTAWA, Aug. 2-Persons who suffer from asthma and hay fever are less likely to die of any kind of cancer,
according to a large Canadian study.
Using an enormous database -- the 1.2-million-strong Cancer Prevention Study II -- epidemiologists have
demonstrated that having asthma, hay fever, or both is associated with a lower risk of dying of cancer.
"The study suggests that there may be a protective effect for cancer mortality in those with allergies,"
said epidemiologist Michelle Turner, MSc, of the University of Ottawa, whose study appears in the current American
Journal of Epidemiology.
Analyzing the records of 1.102 million of the study's 1.2 million participants, Turner and colleagues
found:
• A 12% reduction in risk of dying of all cancers for people with both asthma and hay fever. (The relative
risk was 0.88, with a 95% confidence interval of 0.83 to 0.93.)
• An 8% reduction in risk of dying of all cancers for people with just hay fever. (The relative risk was
0.92, with a confidence interval of 0.89 to 0.94.)
The effect appeared to be driven largely by significant inverse associations with lung and colorectal cancer
mortality. For instance, for people with both conditions, there was 27% reduction in risk of dying of lung cancer
and a 24% reduction in risk of dying of colorectal cancer.
The study also found:
• Hay fever only was associated with a 15% reduction in the risk of pancreatic cancer death.
• Asthma only was associated with a 25% reduction in the risk of leukemia mortality.
On the other hand, a history of asthma alone was also associated with a significantly increased risk of lung
cancer mortality. (The relative risk was 1.11, with a 95% confidence interval of 1.02 to 1.20.)
Turner said in an interview it's not clear why such effects should appear.
"One suggestion is that people with allergies might have better immune surveillance," she said. Equally, there
may be some other unknown difference between people with allergies and the general population, or there may be an
undiscovered effect of allergy medication.
"No one really knows the answer," she said.
Interestingly, among the study participants who had never smoked, most of the associations vanished. Only a
slight protective effect for those with both asthma and hay fever -- a 9% reduction in risk of all-cancer mortality
-- remained significant (RR 0.91; 95% CI 0.83-1.00).
That may be due to the relatively small size -- 448,610 -- of the group who had never smoked, compared to the
whole study population, Turner said.
The longitudinal Cancer Prevention Study II, designed and conducted by the American Cancer Society, enrolled
about 1.2 million U.S. men and women in 1982. The vital status of participants has been determined every two years
since.
Over 18 years of follow-up, there were 81,114 cancer deaths among the participants whose records were analyzed.
The baseline survey listed 25 different medical condition or diseases, including asthma and hay fever, Turner
said.
The comprehensive nature of the baseline survey allowed the researchers to control for a large range of
possible confounding factors, she said, including co-morbid disease, lifestyle factors, diet, diabetes, body mass
index, and family history.
Related articles:
• ATS: Exhalation Test Helps Reduce Steroid Doses for Asthma
http://www.medpagetoday.com/Pulmonary/Asthma/tb1/1117
• ATS: Laughter No Joke To Asthma Patients
http://www.medpagetoday.com/Pulmonary/Asthma/tb1/1106
Primary source: American Journal of Epidemiology. Source reference: Turner, MC et al. Cancer Mortality among
US Men and Women with Asthma and Hay Fever. Am J Epidemiol 2005;162:212-221
________________________________________
Disclaimer: The information presented in this activity is that of the authors and does not necessarily
represent the views of the University of Pennsylvania School of Medicine, MedPage Today, and the commercial
supporter. Specific medicines discussed in this activity may not yet be approved by the FDA for the use as
indicated by the writer or reviewer. Before prescribing any medication, we advise you to review the complete
prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.
Specific patient care decisions are the responsibility of the healthcare professional caring for the patient.
Please review our Terms of Use. © 2004-5 MedPage Today, LLC. All Rights Reserved.
The above is for general informational purposes only. Always consult your
physician regarding specific medical issues and call Hatzalah or your local
ambulance service in the event of an emergency.
Back to Digest Index
|